Evaluation of a Bile Acid-derived Antibiotic that Can Treat Superbug Infection

Antibiotics have revolutionized medicine, saving countless lives since the introduction of penicillin. However, antimicrobial resistance has challenged their efficacy, prompting ongoing efforts to develop new antibiotics. This study aimed to explore the antimicrobial effects of a bile acid derivative, BA-3/4-Butyl, by analyzing its interactions and mechanism of action against bacteria using a variety of assays. It is revealed that BA-3/4-Butyl exerts its antimicrobial activity via membrane permeabilization and that an efflux pump inhibitor and pharmacokinetic constraint exists. The zones of inhibition increased with BA-¾-Butyl concentration. A one-way ANOVA with a significance level (alpha) set at 0.05 gave a p-value of <0.01. These findings provide insights into how BA-3/4-Butyl compromises bacterial membranes without causing toxicity in its mammalian counterparts. This study advances understanding of BA-3/4-Butyl’s antimicrobial activity and potential mechanisms of action, ultimately aiding the development of similar novel therapeutic agents to help combat antimicrobial resistance.